Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Shabila

Vascular & Interventional Radiology Skokie, IL Medical Doctor

NPI 1710398474 CMS profile 3400886

9977 Woods Dr Ste B70, Skokie, IL 60077

Open in the dashboard

General payments

$10,511

69 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrew Shabila of Skokie, IL is reported in the CMS Open Payments database as having received $10,511 across 69 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,087 20
2024 General $2,992 29
2023 General $1,397 12
2022 General $1,856 6
2019 General $179 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Shabila
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Andrew Shabila were reported at $4,087. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Andrew Shabila Vascular & Interventional Radiology median Middle half National median
2019 $179 $422 $125–$1,555 $163
2020 $0 $200 $68–$652 $114
2021 $0 $280 $99–$866 $132
2022 $1,856 $433 $137–$1,497 $149
2023 $1,397 $506 $152–$2,019 $160
2024 $2,992 $556 $175–$1,930 $164
2025 $4,087 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Penumbra, Inc. $4,978 18 payments
  2. Boston Scientific Corporation $1,811 14 payments
  3. Medtronic, Inc. $1,293 12 payments
  4. Sirtex Medical Inc $1,097 10 payments
  5. Terumo Medical Corporation $487 3 payments
  6. Inari Medical, Inc. $263 1 payment
  7. AngioDynamics, Inc. $149 2 payments
  8. Philips Electronics North America Corporation $145 5 payments
  9. Medtronic USA, Inc. $114 1 payment
  10. Surefire Medical, Inc. $95 1 payment
  11. Other $79 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,857 54 payments
  2. Travel and Lodging $4,654 15 payments
Products named General payments · program years 2019–2025
  1. Indigo System $4,828 17 payments
  2. TheraSphere Y90 Glass Microspheres 10 GBq $1,319 7 payments
  3. SIR-Spheres Microspheres $1,097 10 payments
  4. KYPHON EXPRESS II KYPHOPAK TRAY $1,066 10 payments
  5. Azur CX Detachable $316 2 payments
  6. ANGIO-SEAL $308 2 payments
  7. FLOWTRIEVER CATHETER, S $263 1 payment
  8. CT THROMBECTOMY SYSTEM KIT $263 1 payment
  9. General - Interventional Oncology $235 2 payments
  10. RUBY Coil $150 1 payment
  11. Other $1,123 17 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

38

Median for Interventional Radiology: 38

Drug cost

$84

Median for Interventional Radiology: $333

Branded share of claims

0%

Median for Interventional Radiology: 53%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 19 $42
Levofloxacin Generic 19 $42

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 554 Part D prescribers listed as Interventional Radiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 116 billing codes

Paid by Medicare

$66,745

Medicare's payments for the services billed

Medicare patients

302

Average age 68

Services billed

883

147 women, 155 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Diabetes 45%
Depression 41%
Ischemic heart disease 40%
Chronic kidney disease 40%
COPD 39%
Heart failure 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record